NCT02242344View on ClinicalTrials.gov

Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

September 30, 2007

Conditions
Hypertension
Interventions
DRUG

Telmisartan

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02242344 - Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension | Biotech Hunter | Biotech Hunter